Literature DB >> 19048126

Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.

Antonella Tomassetti1, Giuseppina De Santis, Giancarlo Castellano, Silvia Miotti, Mimma Mazzi, Daniela Tomasoni, Frans Van Roy, Maria Luisa Carcangiu, Silvana Canevari.   

Abstract

Ovarian carcinoma arises from the ovarian surface epithelium, which undergoes phenotypic changes characteristic of müllerian epithelium during the first stages of tumorigenesis. The variant isoform of the hepatocyte nuclear factor 1 (vHNF1) is a transcription factor involved in the development of tissues derived from the müllerian duct. Here, we show that vHNF1 knockdown in two ovarian carcinoma cell lines, SKOV3 and IGROV1, leads to reduced E-cadherin (E-cadh) expression and decreased proliferation rate. Accordingly, SKOV3 cells ectopically expressing a dominant-negative (DN) vHNF1 mutant undergo an epithelial-mesenchymal-like transition, acquiring a spindle-like morphology, loss of E-cadh, and disrupted cell-cell contacts. Gene expression profiling of DNvHNF1 cells on the basis of a newly compiled list of epithelial-mesenchymal transition-related genes revealed a correlation between vHNF1 loss-of-function and acquisition of the mesenchymal phenotype. Indeed, phenotypic changes were associated with increased Slug transcription and functionality. Accordingly, vHNF1-transfected immortalized ovarian surface epithelial cells showed down-regulation of Snail and Slug transcripts. In DNvHNF1-transfected SKOV3 cells, growth rate decreased, and in vHNF1-transfected immortalized ovarian surface epithelial cells, growth rate increased. By immunohistochemistry, we found a strong association of vHNF1 with E-cadh in clear cell and in a subset of serous carcinomas, data that could potentially contribute in distinguishing different types of ovarian tumors. Our results may help in understanding the biology of ovarian carcinoma, identifying early detection markers, and opening potential avenues for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048126      PMCID: PMC2586698          DOI: 10.1593/neo.81004

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  43 in total

1.  Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.

Authors:  E Janda; M Nevolo; K Lehmann; J Downward; H Beug; M Grieco
Journal:  Oncogene       Date:  2006-06-05       Impact factor: 9.867

Review 2.  Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.

Authors:  Kevin A David; Matthew I Milowsky; Lale Kostakoglu; Shankar Vallabhajosula; Stanley J Goldsmith; David M Nanus; Neil H Bander
Journal:  Clin Genitourin Cancer       Date:  2006-03       Impact factor: 2.872

3.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.

Authors:  Julius Gudmundsson; Patrick Sulem; Valgerdur Steinthorsdottir; Jon T Bergthorsson; Gudmar Thorleifsson; Andrei Manolescu; Thorunn Rafnar; Daniel Gudbjartsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Thorarinn Blondal; Simon N Stacey; Agnar Helgason; Steinunn Gunnarsdottir; Adalheidur Olafsdottir; Kari T Kristinsson; Birgitta Birgisdottir; Shyamali Ghosh; Steinunn Thorlacius; Dana Magnusdottir; Gerdur Stefansdottir; Kristleifur Kristjansson; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Andrew D Morris; Charlotte H Kimber; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Wing-Yee So; Peter C Y Tong; Maggie C Y Ng; Torben Hansen; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Alejandro Tres; Fernando Fuertes; Manuel Ruiz-Echarri; Laura Asin; Berta Saez; Erica van Boven; Siem Klaver; Dorine W Swinkels; Katja K Aben; Theresa Graif; John Cashy; Brian K Suarez; Onco van Vierssen Trip; Michael L Frigge; Carole Ober; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Colin N A Palmer; Charles Rotimi; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Rafn Benediktsson; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; William J Catalona; Lambertus A Kiemeney; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

Review 4.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

5.  Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Eva Cubillo; David Sarrió; Héctor Peinado; Socorro María Rodríguez-Pinilla; Sonia Villa; Victoria Bolós; Mireia Jordá; Angels Fabra; Francisco Portillo; José Palacios; Amparo Cano
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

6.  Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells.

Authors:  Elena Sanna; Silvia Miotti; Mimma Mazzi; Giuseppina De Santis; Silvana Canevari; Antonella Tomassetti
Journal:  Exp Cell Res       Date:  2007-02-15       Impact factor: 3.905

7.  Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney.

Authors:  Agnès Boutet; Cristina A De Frutos; Patrick H Maxwell; M José Mayol; J Romero; M Angela Nieto
Journal:  EMBO J       Date:  2006-11-09       Impact factor: 11.598

8.  New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies.

Authors:  Giancarlo Castellano; James F Reid; Paola Alberti; Maria Luisa Carcangiu; Antonella Tomassetti; Silvana Canevari
Journal:  Cancer Res       Date:  2006-11-06       Impact factor: 12.701

9.  Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.

Authors:  Sendurai A Mani; Jing Yang; Mary Brooks; Gunda Schwaninger; Alicia Zhou; Naoyuki Miura; Jeffery L Kutok; Kimberly Hartwell; Andrea L Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

Review 10.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

View more
  13 in total

1.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

2.  Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.

Authors:  Kristýna Němejcová; Ivana Tichá; Petra Kleiblová; Michaela Bártů; David Cibula; Kateřina Jirsová; Pavel Dundr
Journal:  Pathol Oncol Res       Date:  2015-12-19       Impact factor: 3.201

3.  Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.

Authors:  Jianbo Wang; Kaihua Zhang; Dorota Grabowska; Aimin Li; Yiyu Dong; Ryan Day; Peter Humphrey; James Lewis; Raleigh D Kladney; Jeffrey M Arbeit; Jason D Weber; Christine H Chung; Loren S Michel
Journal:  Mol Cancer Res       Date:  2011-10-04       Impact factor: 5.852

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Siu Chiu Chan; Ying Zhang; Annie Shao; Svetlana Avdulov; Jeremy Herrera; Karam Aboudehen; Marco Pontoglio; Peter Igarashi
Journal:  J Am Soc Nephrol       Date:  2018-08-10       Impact factor: 10.121

6.  HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines.

Authors:  Laura Pelletier; Sandra Rebouissou; Danijela Vignjevic; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  BMC Cancer       Date:  2011-10-05       Impact factor: 4.430

7.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

8.  Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.

Authors:  Kristýna Němejcová; David Cibula; Pavel Dundr
Journal:  Diagn Pathol       Date:  2015-03-25       Impact factor: 2.644

9.  Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression.

Authors:  Jae Yoon Choi; Hyun Ho Han; Young Tae Kim; Joo Hyun Lee; Baek Gil Kim; Suki Kang; Nam Hoon Cho
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

Review 10.  Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.

Authors:  Francesca Roggiani; Delia Mezzanzanica; Katia Rea; Antonella Tomassetti
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.